ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,977Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 546

$383K Total Retail Price of All Prescriptions

Rank: 112 out of 546

283 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 283 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

7% of this provider’s 283 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 6,538 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
WARFARIN SODIUM 355 349 1 13
SIMVASTATIN 284 260 2 2
LEVOTHYROXINE SODIUM 246 223 3 3
SERTRALINE HCL 201 191 4 14
AMLODIPINE BESYLATE 173 149 5 9
FUROSEMIDE 172 172 6 5
ATORVASTATIN CALCIUM 167 147 7 11
METOPROLOL TARTRATE 166 160 8 6
LISINOPRIL 158 139 9 1
POTASSIUM CHLORIDE 137 137 10 30
ATENOLOL 134 109 11 12
HYDROCHLOROTHIAZIDE 116 115 12 7
OMEPRAZOLE 109 98 13 4
PREDNISONE 98 95 14 29
METFORMIN HCL ER 96 87 15 74
TAMSULOSIN HCL 94 94 16 35
DONEPEZIL HCL 94 94 16 31
HYDROCODONE-ACETAMINOPHEN 87 71 S3 18 8
LOVASTATIN 87 83 18 22
METOPROLOL SUCCINATE 83 79 20 17
METFORMIN HCL 82 78 21 10
LEVETIRACETAM 80 80 22 95
ADVAIR DISKUS 77 71 23 20
GABAPENTIN 72 65 24 16
RANITIDINE HCL 68 57 25 23
ACETIC ACID 66 66 26 187
FENTANYL 65 65 S2 27 50
JANTOVEN 64 62 28 92
NAMENDA 63 63 29 60
LOSARTAN POTASSIUM 62 62 30 24
LIPITOR 59 54 31 80
TRAZODONE HCL 54 51 32 25
MIRTAZAPINE 54 50 32 51
FLUOXETINE HCL 53 48 34 39
ESCITALOPRAM OXALATE 53 53 34 66
NEXIUM 52 41 36 52
GLIPIZIDE ER 51 51 37 126
FLOVENT HFA 51 47 37 139
DIOVAN 51 51 37 65
SPIRIVA 50 49 40 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.